Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 122 Pages
Report ld: 5544118
Request Sample
Customized Report
Transcutaneous Jaundice Detector Market Size(US$)

CAGR 2026-2032
1.3%
Market Size,2032
USD 113
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Transcutaneous Jaundice Detector market was valued at US$ 105 million in 2025 and is anticipated to reach US$ 113 million by 2032, at a CAGR of 1.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Transcutaneous Jaundice Detector competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The core drivers of the development of the Transcutaneous Jaundice Detector industry are twofold. First, the high incidence of neonatal jaundice creates a rigid clinical demand. The prevalence of jaundice in full-term and premature infants makes non-invasive and rapid testing equipment a necessity for neonatal health protection. Second, policy-driven improvements in the neonatal disease screening capabilities of primary healthcare systems, with relevant regulations listing transcutaneous bilirubin testing as a recommended method, coupled with the popularization and upgrading of equipment in primary healthcare institutions, continue to release market demand.
In 2024, global Transcutaneous Jaundice Detectors reached approximately 55,813 Units, with an average global market price of around 1,918.0 USD per Unit.
Transcutaneous Jaundice Detectors are non-invasive medical devices used to measure the level of bilirubin in a patient’s skin, primarily in neonates, to assess the risk of jaundice. These meters work by using light to estimate the bilirubin concentration in the subcutaneous tissue, which can be an indicator of the liver's ability to process bilirubin.
Transcutaneous bilirubin measurement is performed by placing a sensor on the baby’s skin, usually on the forehead or chest, where the skin is thin. The device emits light at specific wavelengths, and based on the amount of light that is absorbed or reflected by the skin, the device calculates the bilirubin level. This method provides a quick, painless alternative to serum bilirubin tests, reducing the need for blood draws.
The upstream core components of Transcutaneous Jaundice Detectors mainly include light sources, photoelectric sensors, filters, microprocessors, etc. Typical suppliers include Hamamatsu Photonics, Nichia, Edmund Optics, Thorlabs, etc. The downstream applications are mainly in hospitals, clinics, community service centers, and postpartum care centers.
The single-line production capacity of Transcutaneous Jaundice Detectors varies significantly depending on the manufacturer's scale, product positioning, and production model. Typically, the single-line production capacity of regular products is over 2,000 units, and the industry gross profit margin is in the range of 40%-60%.
Transcutaneous Jaundice Detectors are non-invasive sentinels protecting newborn health. Designed specifically for neonatal jaundice screening, these medical devices utilize spectral absorption technology. Simply place the probe lightly against the infant's forehead or sternum, and within seconds, the difference in reflection between blue and green light is used to calculate bilirubin levels, completely eliminating the pain and waiting associated with traditional blood tests. From bedside screening in maternity wards to routine monitoring in primary care hospitals and home follow-up, this device, with its non-invasive, rapid, and safe characteristics, has become a key tool for the early detection and intervention of neonatal hyperbilirubinemia, building the first line of defense for the health of millions of newborns worldwide.
The global market for Transcutaneous Jaundice Detectors exhibits a distinct regional development pattern. North America, relying on its mature neonatal healthcare system and high medical investment, has stable and concentrated market demand. Local companies have accumulated deep expertise in device intelligence and clinical adaptability, occupying a core position in the global market. Europe excels in technological precision, with stringent medical standards driving equipment upgrades towards low-interference, high-precision solutions. Products not only serve the well-developed local healthcare network but also radiate globally through technology exports. The Asia-Pacific region has become the core engine of industry growth. China, with its large newborn population and policies promoting the widespread availability of basic medical equipment, has propelled domestic brands from followers to leaders. Meanwhile, emerging markets such as India and Southeast Asia, with their improving healthcare infrastructure, are releasing strong incremental demand. According to our data, in 2024, Asia held nearly 50% of the market share for Transcutaneous Jaundice Detectors, followed by Europe and North America. During the forecast period, emerging markets such as India and Southeast Asia are leading the global growth rate.
From a manufacturer perspective, globally, key manufacturers of Transcutaneous Jaundice Detectors include Dräger, Mennen Medical, Philips, Konica Minolta, Beijing Maibang Optoelectronics, Ningbo Davy Medical, Weicai, AVI Healthcare, NEORUBIN (RECOVE GROUP), Nanjing Daofen Electronics, Likang Biotechnology, Boke Biotechnology, and Micro Lab. According to our data, the top 5 manufacturers accounted for over 70% of the global market share in 2024.
The convergence of multiple demands and policies has injected continuous growth momentum into the Transcutaneous Jaundice Detectors industry. The high incidence of neonatal jaundice forms a rigid demand foundation, while the monitoring needs of premature and high-risk infants further make the equipment a clinical necessity. At the policy level, countries are incorporating neonatal disease screening into their public health systems, while technological innovation is reshaping product value. Multi-wavelength spectral technology overcomes the bottleneck of skin color interference, and intelligent algorithms enable real-time data transmission and trend prediction, upgrading the equipment from a simple testing tool to an entry point for neonatal health management. Meanwhile, the public's growing preference for non-invasive medical care and increased awareness of home health monitoring have further broadened application scenarios, extending from hospitals to homes and forming a full-cycle monitoring ecosystem.
This report delivers a comprehensive overview of the global Transcutaneous Jaundice Detector market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Transcutaneous Jaundice Detector. The Transcutaneous Jaundice Detector market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Transcutaneous Jaundice Detector market comprehensively. Regional market sizes by Type, by Application, by Power Supply Method, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Transcutaneous Jaundice Detector manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Power Supply Method, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Transcutaneous Jaundice Detector manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Transcutaneous Jaundice Detector sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Transcutaneous Jaundice Detector Market Overview
1.1 Product Definition
1.2 Transcutaneous Jaundice Detector by Type
1.2.1 Global Transcutaneous Jaundice Detector Market Value by Type: 2025 vs 2032
1.2.2 Standard Type
1.2.3 Intelligent Type
1.3 Transcutaneous Jaundice Detector by Power Supply Method
1.3.1 Global Transcutaneous Jaundice Detector Market Value by Power Supply Method: 2025 vs 2032
1.3.2 Rechargeable Type
1.3.3 Non-rechargeable Type
1.4 Transcutaneous Jaundice Detector by Technology
1.4.1 Global Transcutaneous Jaundice Detector Market Value by Technology: 2025 vs 2032
1.4.2 Single Measurement Optical Path
1.4.3 Dual Measurement Optical Path
1.5 Transcutaneous Jaundice Detector by Application
1.5.1 Global Transcutaneous Jaundice Detector Market Value by Application: 2025 vs 2032
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Global Transcutaneous Jaundice Detector Market Size Estimates and Forecasts
1.6.1 Global Transcutaneous Jaundice Detector Revenue 2021–2032
1.6.2 Global Transcutaneous Jaundice Detector Sales 2021–2032
1.6.3 Global Transcutaneous Jaundice Detector Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Transcutaneous Jaundice Detector Market Competition by Manufacturers
2.1 Global Transcutaneous Jaundice Detector Sales Market Share by Manufacturers (2021–2026)
2.2 Global Transcutaneous Jaundice Detector Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Transcutaneous Jaundice Detector Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Transcutaneous Jaundice Detector, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Transcutaneous Jaundice Detector, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Transcutaneous Jaundice Detector, Product Types and Applications
2.7 Global Key Manufacturers of Transcutaneous Jaundice Detector, Date of Entry into the Industry
2.8 Global Transcutaneous Jaundice Detector Market Competitive Situation and Trends
2.8.1 Global Transcutaneous Jaundice Detector Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Transcutaneous Jaundice Detector Players Market Share by Revenue
2.8.3 Global Transcutaneous Jaundice Detector Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Transcutaneous Jaundice Detector Market Scenario by Region
3.1 Global Transcutaneous Jaundice Detector Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Transcutaneous Jaundice Detector Sales by Region: 2021–2032
3.2.1 Global Transcutaneous Jaundice Detector Sales by Region: 2021–2026
3.2.2 Global Transcutaneous Jaundice Detector Sales by Region: 2027–2032
3.3 Global Transcutaneous Jaundice Detector Revenue by Region: 2021–2032
3.3.1 Global Transcutaneous Jaundice Detector Revenue by Region: 2021–2026
3.3.2 Global Transcutaneous Jaundice Detector Revenue by Region: 2027–2032
3.4 North America Transcutaneous Jaundice Detector Market Facts & Figures by Country
3.4.1 North America Transcutaneous Jaundice Detector Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Transcutaneous Jaundice Detector Sales by Country (2021–2032)
3.4.3 North America Transcutaneous Jaundice Detector Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Transcutaneous Jaundice Detector Market Facts & Figures by Country
3.5.1 Europe Transcutaneous Jaundice Detector Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Transcutaneous Jaundice Detector Sales by Country (2021–2032)
3.5.3 Europe Transcutaneous Jaundice Detector Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transcutaneous Jaundice Detector Market Facts & Figures by Region
3.6.1 Asia Pacific Transcutaneous Jaundice Detector Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Transcutaneous Jaundice Detector Sales by Region (2021–2032)
3.6.3 Asia Pacific Transcutaneous Jaundice Detector Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Transcutaneous Jaundice Detector Market Facts & Figures by Country
3.7.1 Latin America Transcutaneous Jaundice Detector Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Transcutaneous Jaundice Detector Sales by Country (2021–2032)
3.7.3 Latin America Transcutaneous Jaundice Detector Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transcutaneous Jaundice Detector Market Facts & Figures by Country
3.8.1 Middle East and Africa Transcutaneous Jaundice Detector Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Transcutaneous Jaundice Detector Sales by Country (2021–2032)
3.8.3 Middle East and Africa Transcutaneous Jaundice Detector Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transcutaneous Jaundice Detector Sales by Type (2021–2032)
4.1.1 Global Transcutaneous Jaundice Detector Sales by Type (2021–2026)
4.1.2 Global Transcutaneous Jaundice Detector Sales by Type (2027–2032)
4.1.3 Global Transcutaneous Jaundice Detector Sales Market Share by Type (2021–2032)
4.2 Global Transcutaneous Jaundice Detector Revenue by Type (2021–2032)
4.2.1 Global Transcutaneous Jaundice Detector Revenue by Type (2021–2026)
4.2.2 Global Transcutaneous Jaundice Detector Revenue by Type (2027–2032)
4.2.3 Global Transcutaneous Jaundice Detector Revenue Market Share by Type (2021–2032)
4.3 Global Transcutaneous Jaundice Detector Price by Type (2021–2032)
5 Segment by Application
5.1 Global Transcutaneous Jaundice Detector Sales by Application (2021–2032)
5.1.1 Global Transcutaneous Jaundice Detector Sales by Application (2021–2026)
5.1.2 Global Transcutaneous Jaundice Detector Sales by Application (2027–2032)
5.1.3 Global Transcutaneous Jaundice Detector Sales Market Share by Application (2021–2032)
5.2 Global Transcutaneous Jaundice Detector Revenue by Application (2021–2032)
5.2.1 Global Transcutaneous Jaundice Detector Revenue by Application (2021–2026)
5.2.2 Global Transcutaneous Jaundice Detector Revenue by Application (2027–2032)
5.2.3 Global Transcutaneous Jaundice Detector Revenue Market Share by Application (2021–2032)
5.3 Global Transcutaneous Jaundice Detector Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Dräger
6.1.1 Dräger Company Information
6.1.2 Dräger Description and Business Overview
6.1.3 Dräger Transcutaneous Jaundice Detector Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Dräger Transcutaneous Jaundice Detector Product Portfolio
6.1.5 Dräger Recent Developments/Updates
6.2 Mennen Medical
6.2.1 Mennen Medical Company Information
6.2.2 Mennen Medical Description and Business Overview
6.2.3 Mennen Medical Transcutaneous Jaundice Detector Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Mennen Medical Transcutaneous Jaundice Detector Product Portfolio
6.2.5 Mennen Medical Recent Developments/Updates
6.3 Philips
6.3.1 Philips Company Information
6.3.2 Philips Description and Business Overview
6.3.3 Philips Transcutaneous Jaundice Detector Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Philips Transcutaneous Jaundice Detector Product Portfolio
6.3.5 Philips Recent Developments/Updates
6.4 Konica Minolta
6.4.1 Konica Minolta Company Information
6.4.2 Konica Minolta Description and Business Overview
6.4.3 Konica Minolta Transcutaneous Jaundice Detector Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Konica Minolta Transcutaneous Jaundice Detector Product Portfolio
6.4.5 Konica Minolta Recent Developments/Updates
6.5 Beijing M&B Electronic Instruments
6.5.1 Beijing M&B Electronic Instruments Company Information
6.5.2 Beijing M&B Electronic Instruments Description and Business Overview
6.5.3 Beijing M&B Electronic Instruments Transcutaneous Jaundice Detector Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Beijing M&B Electronic Instruments Transcutaneous Jaundice Detector Product Portfolio
6.5.5 Beijing M&B Electronic Instruments Recent Developments/Updates
6.6 Ningbo David Medical Device
6.6.1 Ningbo David Medical Device Company Information
6.6.2 Ningbo David Medical Device Description and Business Overview
6.6.3 Ningbo David Medical Device Transcutaneous Jaundice Detector Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Ningbo David Medical Device Transcutaneous Jaundice Detector Product Portfolio
6.6.5 Ningbo David Medical Device Recent Developments/Updates
6.7 VECH MEDICAL
6.7.1 VECH MEDICAL Company Information
6.7.2 VECH MEDICAL Description and Business Overview
6.7.3 VECH MEDICAL Transcutaneous Jaundice Detector Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 VECH MEDICAL Transcutaneous Jaundice Detector Product Portfolio
6.7.5 VECH MEDICAL Recent Developments/Updates
6.8 AVI Healthcare
6.8.1 AVI Healthcare Company Information
6.8.2 AVI Healthcare Description and Business Overview
6.8.3 AVI Healthcare Transcutaneous Jaundice Detector Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 AVI Healthcare Transcutaneous Jaundice Detector Product Portfolio
6.8.5 AVI Healthcare Recent Developments/Updates
6.9 NEORUBIN (RECOVE GROUP)
6.9.1 NEORUBIN (RECOVE GROUP) Company Information
6.9.2 NEORUBIN (RECOVE GROUP) Description and Business Overview
6.9.3 NEORUBIN (RECOVE GROUP) Transcutaneous Jaundice Detector Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 NEORUBIN (RECOVE GROUP) Transcutaneous Jaundice Detector Product Portfolio
6.9.5 NEORUBIN (RECOVE GROUP) Recent Developments/Updates
6.10 Dolphin Nanjing electronics
6.10.1 Dolphin Nanjing electronics Company Information
6.10.2 Dolphin Nanjing electronics Description and Business Overview
6.10.3 Dolphin Nanjing electronics Transcutaneous Jaundice Detector Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Dolphin Nanjing electronics Transcutaneous Jaundice Detector Product Portfolio
6.10.5 Dolphin Nanjing electronics Recent Developments/Updates
6.11 Heal Force
6.11.1 Heal Force Company Information
6.11.2 Heal Force Description and Business Overview
6.11.3 Heal Force Transcutaneous Jaundice Detector Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Heal Force Transcutaneous Jaundice Detector Product Portfolio
6.11.5 Heal Force Recent Developments/Updates
6.12 BIOBASE GROUP
6.12.1 BIOBASE GROUP Company Information
6.12.2 BIOBASE GROUP Description and Business Overview
6.12.3 BIOBASE GROUP Transcutaneous Jaundice Detector Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 BIOBASE GROUP Transcutaneous Jaundice Detector Product Portfolio
6.12.5 BIOBASE GROUP Recent Developments/Updates
6.13 Micro Lab
6.13.1 Micro Lab Company Information
6.13.2 Micro Lab Description and Business Overview
6.13.3 Micro Lab Transcutaneous Jaundice Detector Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Micro Lab Transcutaneous Jaundice Detector Product Portfolio
6.13.5 Micro Lab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transcutaneous Jaundice Detector Industry Chain Analysis
7.2 Transcutaneous Jaundice Detector Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transcutaneous Jaundice Detector Production Mode & Process Analysis
7.4 Transcutaneous Jaundice Detector Sales and Marketing
7.4.1 Transcutaneous Jaundice Detector Sales Channels
7.4.2 Transcutaneous Jaundice Detector Distributors
7.5 Transcutaneous Jaundice Detector Customer Analysis
8 Transcutaneous Jaundice Detector Market Dynamics
8.1 Transcutaneous Jaundice Detector Industry Trends
8.2 Transcutaneous Jaundice Detector Market Drivers
8.3 Transcutaneous Jaundice Detector Market Challenges
8.4 Transcutaneous Jaundice Detector Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Transcutaneous Jaundice Detector market size was US$ 105 million in 2025 and is forecast to reach a readjusted size of US$ 113 million by 2032 with a CAGR of 1.3% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 96
USD 4250.00
(Single User License)
The global market for Transcutaneous Jaundice Detector was estimated to be worth US$ 105 million in 2025 and is projected to reach US$ 113 million, growing at a CAGR of 1.3% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 114
USD 3950.00
(Single User License)
The global Transcutaneous Jaundice Detector market size was US$ 3084 million in 2024 and is forecast to a readjusted size of US$ 4551 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 102
USD 4250.00
(Single User License)
The global Transcutaneous Jaundice Detector market is projected to grow from US$ 3084 million in 2024 to US$ 4551 million by 2031, at a CAGR of 5.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 176
USD 4900.00
(Single User License)
The global market for Transcutaneous Jaundice Detector was estimated to be worth US$ 3084 million in 2024 and is forecast to a readjusted size of US$ 4551 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 134
USD 3950.00
(Single User License)
The global market for Transcutaneous Jaundice Detector was valued at US$ 3084 million in the year 2024 and is projected to reach a revised size of US$ 4551 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Published Date: 2025-01-13
Pages: 99
USD 2900.00
(Single User License)
Transcutaneous Jaundice Detector is a instrument used in the dynamic clinical examination of neonatal jaundice.
Published Date: 2024-01-17
Pages: 99
USD 2900.00
(Single User License)
The global Transcutaneous Jaundice Detector market size was US$ 105 million in 2025 and is forecast to reach a readjusted size of US$ 113 million by 2032 with a CAGR of 1.3% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 96
The global market for Transcutaneous Jaundice Detector was estimated to be worth US$ 105 million in 2025 and is projected to reach US$ 113 million, growing at a CAGR of 1.3% from 2026 to 2032.
Published: 2026-03-06
Pages: 114
The global Transcutaneous Jaundice Detector market size was US$ 3084 million in 2024 and is forecast to a readjusted size of US$ 4551 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 102
The global Transcutaneous Jaundice Detector market is projected to grow from US$ 3084 million in 2024 to US$ 4551 million by 2031, at a CAGR of 5.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 176
The global market for Transcutaneous Jaundice Detector was estimated to be worth US$ 3084 million in 2024 and is forecast to a readjusted size of US$ 4551 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 134
The global market for Transcutaneous Jaundice Detector was valued at US$ 3084 million in the year 2024 and is projected to reach a revised size of US$ 4551 million by 2031, growing at a CAGR of 5.8% during the forecast period.
Published: 2025-01-13
Pages: 99
Transcutaneous Jaundice Detector is a instrument used in the dynamic clinical examination of neonatal jaundice.
Published: 2024-01-17
Pages: 99
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now